According to Fortune Business Insights, the global poultry vaccines market was valued at USD 1.32 billion in 2025 and is expected to increase from USD 1.38 billion in 2026 to USD 2.38 billion by 2034, registering a CAGR of 6.99% during the forecast period. North America held the leading position in the market, accounting for a 46.11% share of global revenue in 2025.
The global poultry vaccines market is witnessing steady growth due to the increasing prevalence of infectious poultry diseases, rising demand for high-quality poultry products, and growing awareness among farmers regarding disease prevention. Vaccination has become a crucial component of poultry health management, helping producers minimize economic losses, improve flock productivity, and ensure food safety.
Information Source: https://www.fortunebusinessinsights.com/poultry-vaccines-market-113875
Market Growth Drivers
One of the major factors driving the poultry vaccines market is the growing global consumption of poultry meat and eggs. Poultry remains one of the most affordable and widely consumed protein sources, leading to the expansion of commercial poultry farming. As flock sizes increase, the risk of disease outbreaks also rises, creating a greater need for effective vaccination programs.
The emergence of diseases such as Newcastle disease, avian influenza, infectious bronchitis, Marek’s disease, and infectious bursal disease has encouraged poultry producers to adopt preventive healthcare measures. Vaccination helps reduce mortality rates, improve bird health, and maintain production efficiency. Governments and veterinary organizations across several countries are also promoting vaccination programs to strengthen food security and protect the livestock industry.
Technological advancements in vaccine development are further supporting market growth. Manufacturers are increasingly investing in recombinant vaccines, vector vaccines, and combination vaccines that provide broader protection and improved efficacy. These innovations help poultry producers manage disease risks more effectively while reducing operational costs.
Rising Focus on Poultry Health
The poultry industry is becoming increasingly focused on biosecurity and disease management. Frequent outbreaks of infectious diseases can result in significant economic losses due to reduced productivity, trade restrictions, and culling of infected birds. As a result, poultry farmers are prioritizing preventive healthcare strategies, including routine vaccination.
Growing awareness regarding animal welfare and food safety is also contributing to market expansion. Consumers are demanding safer and healthier poultry products, prompting producers to invest in advanced disease prevention measures. This trend is expected to create new growth opportunities for vaccine manufacturers in both developed and emerging markets.
Market Segmentation
The poultry vaccines market can be segmented based on vaccine type, disease indication, dosage form, route of administration, and distribution channel.
By vaccine type, the market includes live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. Live attenuated vaccines hold a significant market share due to their ability to provide strong and long-lasting immunity.
Based on disease indication, vaccines are used to prevent Newcastle disease, infectious bronchitis, Marek’s disease, avian influenza, infectious bursal disease, and other poultry infections. Newcastle disease vaccines represent a major segment because of the widespread occurrence of the disease across poultry-producing regions.
According to route of administration, vaccines are delivered through spray, drinking water, injection, and other methods. Mass vaccination techniques such as spray and drinking water administration are gaining popularity in large-scale poultry operations due to their efficiency and convenience.
Regional Insights
North America holds a substantial share of the poultry vaccines market, supported by advanced poultry farming practices, strong veterinary infrastructure, and high adoption of vaccination programs. The presence of leading animal health companies further strengthens regional growth.
Europe also represents a significant market due to stringent animal health regulations and increasing emphasis on disease prevention. Countries across the region continue to invest in poultry health management to maintain production standards and food safety requirements.
The Asia Pacific region is expected to witness the fastest growth during the forecast period. Rapid expansion of poultry farming, rising meat consumption, and increasing awareness regarding livestock health are driving demand for poultry vaccines in countries such as China, India, and Southeast Asian nations. Growing investments in veterinary healthcare are expected to support long-term market development.